Called out for tripling price of potential drug for Covid patients, company says increase planned for months
May 05, 2020 at 16:41 PM EDT
The drug is approved for HIV/AIDS patients whose antiretroviral therapies causes diarrhea, but the company sought emergency clearance for Covid-19 patients as well.
